These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1298986)

  • 1. Novel thrombolytic therapy discovered from traditional oriental medicine using the earthworm.
    Mihara H; Maruyama M; Sumi H
    Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():131-40. PubMed ID: 1298986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel fibrinolytic enzyme extracted from the earthworm, Lumbricus rubellus.
    Mihara H; Sumi H; Yoneta T; Mizumoto H; Ikeda R; Seiki M; Maruyama M
    Jpn J Physiol; 1991; 41(3):461-72. PubMed ID: 1960890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of potent fibrinolytic enzymes in earthworm, Lumbricus rubellus.
    Nakajima N; Mihara H; Sumi H
    Biosci Biotechnol Biochem; 1993 Oct; 57(10):1726-30. PubMed ID: 7764268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation.
    Eisenberg PR; Sherman LA; Tiefenbrunn AJ; Ludbrook PA; Sobel BE; Jaffe AS
    Thromb Haemost; 1987 Feb; 57(1):35-40. PubMed ID: 3109058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
    Ieko M
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of thein vivo antithrombotic, anticoagulant and fibrinolytic activities ofLumbricus rubellus earthworm powder.
    Hahn BS; Jo YY; Yang KY; Wu SJ; Pyo MK; Yun-Choi HS; Kim YS
    Arch Pharm Res; 1997 Feb; 20(1):17-23. PubMed ID: 18975206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolytic enzymes extracted from the earthworm. Lumbricus rubellus: a possible thrombolytic agent].
    Mihara H
    Nihon Seirigaku Zasshi; 1991; 53(7):231-43. PubMed ID: 1941660
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin.
    Eriksson E; Wollter IM; Christenson B; Stigendal L; Risberg B
    Thromb Haemost; 1988 Apr; 59(2):284-8. PubMed ID: 2838926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose dependency of earthworm powder on antithrombotic and fibrinolytic effects.
    Kim YS; Pyo MK; Park KM; Hahn BS; Yang KY; Yun-Choi HS
    Arch Pharm Res; 1998 Aug; 21(4):374-7. PubMed ID: 9875462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of six fibrinolytic serine-proteases from earthworm Lumbricus rubellus.
    Cho IH; Choi ES; Lim HG; Lee HH
    J Biochem Mol Biol; 2004 Mar; 37(2):199-205. PubMed ID: 15469696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis.
    Declerck PJ; Mombaerts P; Holvoet P; De Mol M; Collen D
    Thromb Haemost; 1987 Dec; 58(4):1024-9. PubMed ID: 3127914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.